31. The Respondent’s Patient Consultation List states that the Respondent
conducted two telemedicine appointments on July 14, 2021, around the time of her hospital
admission.

The Respondent’s Prescriptions

32. As part of its investigation, the Board subpoenaed the Prescription Records
to review the Respondent’s prescribing practices.®

33. The Board’s investigation determined that the Respondent prescribed a
controlled dangerous substance (the “CDS”) to an immediate family member (the “Family
Member”).

34. The Prescription Records showed that the Respondent wrote the Family
Member prescriptions for the CDS ten (10) times between August 11, 2020 and June 18,
2021. Most of the prescriptions authorized refills.

The Respondent’s Interview

35. On or around September 3, 2021, Board investigators conducted an under-
oath interview with the Respondent. The Respondent stated:

a. Her telemedicine appointments occur “on demand,” she usually signs
in in the morning and signs off in the evening around 5 or 6 p.m., and she has twenty

(20) to twenty-five (25) telemedicine appointments each day.

* The Board obtained a report of the Respondent’s prescribing history through the Maryland Prescription
Drug Monitoring Program (“PDMP”), which the PDMP provided in response to a Board subpoena.

i1
